Multidrug-resistant gram-negative infections in transplant and oncology patients

Mehreen Arshad, Andrew Nowalk, Pranita D. Tamma

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Abstract

Multidrug-resistant gram-negative infections cause significant mortality and morbidity in the transplant and oncology patient population. Prolonged hospitalization and prior exposure to broad-spectrum antibiotics are common risk factors. Prevention strategies include daily bathing with chlorhexidine gluconate and use of isolation precautions. Recent data suggest that carbapenems provide adequate empiric therapy for most patients. However, culture data should be closely monitored to avoid overuse of broad-spectrum therapy.

Original languageEnglish (US)
Title of host publicationPediatric Transplant and Oncology Infectious Diseases
PublisherElsevier
Pages97-102.e3
ISBN (Electronic)9780323641982
DOIs
StatePublished - Jan 1 2020

Keywords

  • Epidemiology
  • Gram-negatives
  • Immunocompromised
  • Multidrug-resistance
  • Prevention
  • Treatment

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Multidrug-resistant gram-negative infections in transplant and oncology patients'. Together they form a unique fingerprint.

Cite this